Brokerages Set McKesson Corporation (NYSE:MCK) Target Price at $943.50

McKesson Corporation (NYSE:MCK) has been assigned a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $943.50.

Several research firms recently commented on MCK. Evercore reaffirmed an “outperform” rating and issued a $1,000.00 price target on shares of McKesson in a research note on Thursday, November 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Robert W. Baird set a $968.00 price objective on McKesson in a research note on Wednesday, January 14th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th.

Insider Buying and Selling at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Maria Martinez sold 349 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the transaction, the director owned 301 shares in the company, valued at approximately $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 1,143 shares of company stock valued at $1,046,070 in the last ninety days. 0.08% of the stock is owned by insiders.

Hedge Funds Weigh In On McKesson

A number of large investors have recently bought and sold shares of MCK. Norges Bank purchased a new position in shares of McKesson in the 4th quarter valued at $1,651,137,000. Alliancebernstein L.P. boosted its position in McKesson by 150.4% during the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock valued at $1,661,956,000 after purchasing an additional 1,362,386 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in McKesson by 56.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after purchasing an additional 446,060 shares during the last quarter. Swedbank AB raised its holdings in McKesson by 42.2% in the fourth quarter. Swedbank AB now owns 886,283 shares of the company’s stock worth $727,009,000 after purchasing an additional 263,189 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its holdings in McKesson by 45.6% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock worth $610,977,000 after purchasing an additional 261,296 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

McKesson Stock Performance

Shares of MCK stock opened at $995.05 on Wednesday. The stock has a 50 day moving average price of $875.61 and a 200 day moving average price of $812.05. McKesson has a 52-week low of $621.88 and a 52-week high of $999.00. The firm has a market capitalization of $121.88 billion, a P/E ratio of 28.62, a P/E/G ratio of 1.59 and a beta of 0.38.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same quarter last year, the firm posted $8.03 earnings per share. The business’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts forecast that McKesson will post 32.77 EPS for the current year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.